Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › gliclazide

gliclazide

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of gliclazide

6 trials tracked of gliclazide: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 14 citations.

6Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 1 Phase 2 1 Phase 1 2
  1. Phase 4 A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313) Completed · 14 cited
  2. Phase 4 Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment Completed
  3. Phase 3 A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253) Completed
  4. Phase 2 Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial. Completed
  5. Phase 1 Bioequivalence and Drug - Drug Interaction Study of Metformin/Gliclazide in Healthy Participants Completed
  6. Phase 1 Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers Completed

Showing the 6 most-cited and recently-updated of 6 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Gliclazide MR before exercise improves performance and recovery markers in strength-trained men
Physical Medicine & Rehab RCT
Gliclazide MR before exercise improves performance and recovery markers in strength-trained men Could a diabetes drug help lifters recover faster from tough workouts?
A randomized controlled trial in 44 strength-trained men found that a single 90 mg dose of gliclazide MR taken 8 hours before exercise incre…
A single dose of a diabetes drug helped lifters lift 23% more weight and recover 32% better after workouts, but caused low blood sugar in so…
Apr 12, 2026